1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The link for this program now points to a previous cycle.
Prior eligibility: Nonprofits, Universities, State/local governments.
Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional) is sponsored by Office of Strategic Coordination (OSC), NIH. Supports the development of new approach methodologies for regulatory testing through technology development centers.
NOT-RM-26-004 asks the public for NIH-wide research challenges worth a 10-year, cross-institute program. There is no budget, no biosketch, no page limit, and no award. What there is: the five criteria every Common Fund investment has met since 2006, a new bullet about small-lab burden, and a fund whose FY 2026 request came in at $347.4 million — down 49.3 percent.
Read articleNIH's FY2026 omnibus adds a Phase IIB Strategic Breakthrough Award up to $30M — but it requires a 100% outside match. Here's who it's for and how to plan.
Read articleThe NIH 2027-2031 strategic plan will guide roughly $250 billion in research funding decisions. Public comment is open, and the first webinar already happened. Here is how to make your input count.
Read article